Foster, Shonda A <br/><br/>
Fractures in women treated with raloxifene or alendronate: a retrospective database analysis.  [electronic resource] 

 -  BMC women's health  Mar 2013 
 - 15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1472-6874 
<br/><br/><label>Standard No.: </label>10.1186/1472-6874-13-15  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alendronate--administration & dosage<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Breast Neoplasms--epidemiology<br/>Cohort Studies<br/>Comorbidity<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Osteoporotic Fractures--epidemiology<br/>Raloxifene Hydrochloride--administration & dosage<br/>Retrospective Studies<br/>United States--epidemiology<br/>Women's Health